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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
This review aims to look at the benefits and harms of different PD catheter insertion techniques.
1. To establish whether a specific technique used to place catheters in adults and children, who are new to PD, result in any
significant differences in clinical outcomes. Insertion techniques will be further defined as peritoneoscopic, percutaneous,
fluoroscopic, laparoscopic insertion or open surgery.
2. To identify which technique offers optimal clinical outcomes and minimises post-procedure complications including
postoperative haemorrhage, PD catheter dysfunction, exit site infection/peritonitis and bowel perforation.
B A C K G R O U N D
Description of the condition
Peritoneal dialysis (PD) is a form of renal replacement therapy
(RRT) used to treat end-stage kidney disease (ESKD). The man-
agement of ESKD is of increasing clinical relevance given world-
wide trends for ESKD prevalence and incidence. In the United
States (US) alone, the US Renal Data System (USRDS) reports an
incidence of 350 permillion population with over 871,000 people
requiring treatment (USRDS 2015). Similarly within the United
Kingdom (UK), recent UK Renal Registry data shows an increas-
ing incidence of patients requiring RRT with over 7000 new pa-
tients dialysing in 2014 (Gilg 2016; MacNeill 2016). PD utilises
the peritoneum as a semi-permeable membrane which allows the
removal of waste electrolytes and water by instillation of dialysate
into the abdominal cavity. This process requires the insertion of
a flexible plastic tube, the PD catheter, into the peritoneal space.
Optimal catheter functionality is necessary for the success of PD
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as a dialysis modality.
Approximately 11% of the global dialysis population are treated
with PD. Notably such utilisation varies internationally (
ANZDATA 2015; Jain 2012; USRDS 2015) with apparent un-
der-utilisation in developed countries despite equivalence to other
other therapeutic modalities in terms of patient outcomes and
economic efficiency (Klarenbach 2009). In the US in 2009, of
the approximate 400,000 patients requiring dialysis, only 27,000
received PD (USRDS 2015). The reasons for variation are poorly
understood and may relate to PD practice variation. Perl 2015
demonstrated that patients were more likely to receive PD if the
catheter was inserted by a nephrologist in comparison to surgi-
cal catheter insertion. Such observations have led to the hypoth-
esis that the pathway to catheter insertion is a critical determi-
nant of the selection of PD as a therapeutic modality (Asif 2005;
Castledine 2013). Thus, the Peritoneal Dialysis Outcomes and
Practice Patterns (PDOPPS) study, an international observational
cohort study, (Perl 2016) has been established to follow PD pa-
tients longitudinally with the aim of defining best practice, includ-
ing techniques relating to PD catheter insertion.
In the paediatric population, among patients intended for kidney
transplantation, PD is the RRT of choice due to better preserva-
tion of residual kidney function in comparison to haemodialysis
(HD) which in turn allows administration of larger feeding vol-
umes. PD is also also preferred due to avoidance of vascular ac-
cess. Surprisingly utilisation of paediatric PD in the UK has fallen
over the last 14 years from 55%, in the period 2000 to 2004, to
44% in 2014. Although this may be explained by a rise in pre-
emptive kidney transplantation, variability in data collection in
the paediatric ESKD population is a challenge and is likely due to
adult data collection systems being arbitrarily applied to children
(UKRR Report 2016a).
Description of the intervention
The primary objective of PD catheter placement is to obtain ac-
cess to the peritoneal cavity to allow effective exchange of dialysate
fluid. Several different techniques are used to achieve this. Many
centres rely on a single surgical approach (including open surgical
and laparoscopic techniques) whereas others practice a combina-
tion of insertion techniques (Rao 2015). PD catheter insertion
techniques commonly in use include: fluoroscopic, percutaneous
and peritoneoscopic, laparoscopic and open surgical.
Laparoscopic insertion involves abdominal insufflation and small
incisions in the abdominal wall though which surgical instru-
ments can be inserted into the abdominal cavity. The PD catheter
is advanced into to the pelvic cavity and the distal end tun-
nelled through the abdominal wall to an exit site incision (NICE
2007). Additional procedures can be performed simultaneously
(e.g. omentectomy and hernia repair). Peritoneoscopic insertion
also allows direct vision of the pelvic cavity however manipulation
of the tube position or other procedures cannot be performed.
Open surgical catheter insertion is perhaps themost common tech-
nique used to place a PD catheter (UKRR Report 2016b; Wallace
2016). A small open incision is made in the abdomen through
the skin, subcutaneous tissue and anterior rectus sheath. A further
small incision is made to the peritoneal cavity and the catheter is
threaded into the pelvis (NICE 2007). The posterior rectus sheath
and the peritoneum are sutured tightly around the catheter with
the other end of the catheter then tunnelled subcutaneously to an
exit site incision in the abdomen. A variant of the open-surgical
technique is the ’mini-laparotomy’, where the abdominal incision
is minimised to allow the use of local rather than general anaes-
thetic.
Percutaneous catheter insertion requires a small incision to be
made in the abdomen followed by blunt dissection of the subcuta-
neous tissue. A catheter guide is used to direct the catheter into the
peritoneal cavity (Seldinger 1953). The other end of the catheter
is tunnelled through to an exit site incision in the abdomen. Fluo-
roscopy is a variation on the percutaneous technique, with the use
of X-rays to guide the placement of the catheter. The ’Moncrieff ’
approach describes burying the external end of the catheter un-
der the skin until it is required to perform dialysis. The choice of
technique is influenced predominantly by those facilities available
(operating theatre access, availability of trained staff ) but in cen-
tres where more than one catheter insertion technique is in use,
the decision to perform a particular technique may be determined
by patient factors such as suitability for general anaesthesia or the
requirement for other procedures (e.g. hernia repair).
How the intervention might work
Successful PD relies on adequate function of the PD catheter. A
poorly functioning catheter often leads to the abandonment of
the modality completely with high levels of patient and clinician
frustration. There is currently no consensus as to the best method
of PD catheter insertion. In the 2012 UK national PD access audit
catheters inserted percutaneously were twice as likely to fail (7%
versus 14% failure at 3 months) (Briggs 2014).
A systematic review by Xie 2012 compared laparoscopic and open
surgical PD catheter insertion finding no significant difference
in outcomes, however Hagen 2013 found that the laparoscopic
technique had significantly favourable outcomes, this was felt
to be related to differing selection criteria of studies. The im-
pact of catheter type and insertion technique on peritonitis rates
in patients on PD (Strippoli 2004a; Strippoli 2004b) has also
been examined - no catheter interventions were identified to have
any impact on peritonitis rates. Importantly, they also identi-
fied that the current available data is significantly flawed. Hagen
2014 examined catheter type in relation to functional outcome,
which favoured a straight intra peritoneal segment (influencing
PD catheter survival at two years) however there was little differ-
ence in the functional outcome at one year.
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Several procedural techniques are being increasingly used for PD
catheter insertion in a medical rather than a surgical setting espe-
cially in the management of late presenting patients. Data from
the 2014 UK Renal Registry (Briggs 2014) reports highlights
that in the UK approximately 40% of late presenting patients
(who had a PD tube inserted), had this done by the percutaneous
route. Boujelbane 2015 examine whether catheters placed percu-
taneously had any benefits over those placed surgically. There was
no significant benefit (or indeed detriment) to having a catheter
placed percutaneously over a surgical insertion.
Data from the paediatric population is much less well defined,
however the Italian Registry of Paediatric Chronic Peritoneal Dial-
ysis reported that all PD catheters were surgically implanted and
over 80% of patients underwent omentectomy (Rinaldi 2004).
In the paediatric population, current guidance recommends par-
tial omentectomy as a standard procedure in infants undergoing
PD catheter insertion due to the higher rates of catheter dysfunc-
tion (Watson 2001; Zurowska 2013). Although the open surgi-
cal method of catheter insertion is recommended, there is lim-
ited available evidence. Specific factors to be taken into account in
children include abdominal wall abnormalities, the presence of os-
tomies, and the presence of absence of nappies must also be taken
into account especially in patients under the age of two years.
Why it is important to do this review
Currently no consensus existswith regards to the optimummethod
of PD catheter insertion and clinical guidelines are therefore lack-
ing in clarity and consistency. The objective of this review is to
examine all possible PD catheter insertion techniques, functional
outcomes on PD and post-procedural complication rates thus
broadening the scope of earlier reviews with the intention to max-
imise the uptake of PD as an RRT. Published guidelines relating to
PD catheter functionality and post-insertion complication thresh-
olds do exist, (ISPD) (Figueiredo 2010), European Best Practice
Guidelines for PeritonealDialysis (EBPG 2005), and theRenal As-
sociation (Mactier 2011)) however their validity has not been rig-
orously evaluated. Current Renal Association guidelines (Mactier
2011; Wilkie 2009) state that timely surgical review to facilitate
PD access however there is no recommended insertion technique
as clear evidence is lacking. Surgical technique under direct vision
is supported for patients with previous complex abdominal surgery
however there is no direct evidence to support this approach. Eu-
ropean guidance does not recommend a particular method of PD
catheter placement stating that insertion technique is dependent
on centre expertise and highlights the difficulty with generalisa-
tion (EBPG 2005).
O B J E C T I V E S
This review aims to look at the benefits and harms of different PD
catheter insertion techniques.
1. To establish whether a specific technique used to place
catheters in adults and children, who are new to PD, result in any
significant differences in clinical outcomes. Insertion techniques
will be further defined as peritoneoscopic, percutaneous,
fluoroscopic, laparoscopic insertion or open surgery.
2. To identify which technique offers optimal clinical
outcomes and minimises post-procedure complications
including postoperative haemorrhage, PD catheter dysfunction,
exit site infection/peritonitis and bowel perforation.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All RCTs and quasi-RCTs (RCTs in which allocation to treatment
was obtained by alternation, use of alternate medical records, date
of birth or other predictable methods) comparing PD catheter
insertion techniques.
Types of participants
Inclusion criteria
Participants to be included in this review are both adults and
children with kidney disease, who require dialysis treatment. This
will include all patients with ESKDand acute kidney injury (AKI).
Participants will have had a PD catheter inserted - this will include
first PD catheter or subsequent catheters. Late presenting patients
and those requiring emergency placement of a PD catheter will
also be included.
Exclusion criteria
There are no exclusion criteria based on the type of participants.
Types of interventions
Studies comparing any two different PD catheter insertion tech-
niques will be included in this review.
PD catheter insertion techniques can be broadly defined as ’medi-
cal’ or ’surgical’ in nature. ’Medical’ techniques, for the purpose of
this review, will include blind percutaneous, peritoneoscopic and
fluoroscopic catheter insertion. ’Surgical’ PD catheter insertion
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techniques will include laparoscopic or open surgical insertion or
any variation thereof.
Studies will not be excluded based on operator type. Studies com-
paring twomedical or two surgical techniques will also be included
(e.g. percutaneous versus peritoneoscopic).
Studies comparing any two catheter insertion techniques will be
included - comparison of the following techniques will be in-
cluded:
1. Percutaneous PD catheter insertion
2. Fluoroscopic PD catheter insertion
3. Peritoneoscopic PD catheter insertion
4. Open surgical PD catheter insertion
5. Laparoscopic PD catheter insertion
Studies comparing other catheter insertion techniques will also
be considered for inclusion including hybrid techniques such as
procedures incorporating ’mini-lap’ PD catheter insertion.
Types of outcome measures
Primary outcomes
1. Early PD catheter function - Catheter function at the time
of PD catheter insertion (primary catheter function) and up to
30 days following PD catheter insertion. If the observation
period is commenced from the start of PD then this will also be
collected. Early catheter failure is indicated by an event which
means the catheter cannot be used to perform a PD exchange/
effective PD treatment (which may or may not require transfer
to HD)
2. ’Long term’ PD catheter function - This should be defined
as functional PD catheter, with the ability to perform successful
PD/PD exchange, post catheter insertion censored for death,
transplantation or transfer to HD (for reasons other than PD
catheter dysfunction) from 30 days to 2 years. PD catheter
failure rate at 1 year will also be collected if reported in studies.
Catheter failure may or may not result in transfer to HD.
3. Technique failure i.e. the inability to perform successful PD
resulting in transfer to HD.
◦ Technique failure will be defined as minimum
duration of temporary period on HD as described by Lan 2016 -
the patient to have been off PD and established on HD for 30
days before technique failure diagnosed. Percentage returning to
returned to PD within 12 months if the duration on HD was 30
days or less was 24% but significantly lower when examining
patients with a longer duration on PD (return after 180 days on
PD - 3%). This is a potentially useful definition of permanent
technique failure. Mechanical causes for technique failure were
highest in the 30 day duration of HD cohort making it a useful
definition in this situation for early technique failure with a
predominantly mechanical aetiology.
◦ 30 day transfer to HD and 180 day transfer to HD
data will therefore be collected if reported.
◦ Death will be considered technique failure however
death censored technique failure will also be reported separately.
Kidney recovery and transplantation will not be classified as
technique failure.
4. Complications of PD catheter insertion will be examined as
primary outcome measures. These will include:
◦ Exit site infection (early as defined within studies)
◦ Early peritonitis episode within 30 days of PD
catheter insertion
◦ Bowel perforation
◦ Haemorrhage/haemoperitoneum
◦ Catheter tip migration
◦ PD catheter drainage pain
◦ Exit site leak
5. Mortality
6. Catheter use - was the PD catheter ever used for PD
7. Data regarding patient characteristics (age, gender, co-
morbidity, primary kidney diagnosis, previous PD catheter
surgery, body mass index (BMI), diabetic status) will be collected
and information about technique of PD catheter insertion
including operator and number of operators per centre.
8. Details regarding the study such as sample size, study
design, length of follow-up and funding source will also be
collected.
9. Uncertainties identified in the publications during data
extraction will be clarified with the authors where possible
Secondary outcomes
• Additional procedures performed at time of catheter
insertion (e.g. omentopexy/hernia repair)
• Catheter type (Swan neck versus straight catheter, number
of cuffs)
• Whether patients were able to receive their chosen modality
- i.e. automated PD (APD) versus continuous ambulatory PD
(CAPD)
• Length of hospital stay
• Estimated glomerular filtration rate (eGFR) at time of PD
catheter insertion
• Re-admission to hospital and further intervention/
procedures
• Patient reported outcomes e.g. patient satisfaction, health
related quality of life measures
• Cost analysis of PD catheter insertion
Search methods for identification of studies
Electronic searches
We will search the Cochrane Kidney and Transplant Specialised
Register through contact with the Information Specialist using
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search terms relevant to this review. The Specialised Register con-
tains studies identified from the following sources.
1. Monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL)
2. Weekly searches of MEDLINE OVID SP
3. Handsearching of kidney-related journals and the
proceedings of major kidney conferences
4. Searching of the current year of EMBASE OVID SP
5. Weekly current awareness alerts for selected kidney and
transplant journals
6. Searches of the International Clinical Trials Register
(ICTRP) Search Portal and ClinicalTrials.gov.
Studies contained in the SpecialisedRegister are identified through
search strategies for CENTRAL,MEDLINE, andEMBASE based
on the scope of Cochrane Kidney and Transplant. Details of these
strategies, as well as a list of handsearched journals, conference
proceedings and current awareness alerts, are available in the Spe-
cialised Register section of information about Cochrane Kidney
and Transplant.
See Appendix 1 for search terms used in strategies for this review.
Searching other resources
1. Reference lists of review articles, relevant studies and
clinical practice guidelines.
2. Letters seeking information about unpublished or
incomplete studies to investigators known to be involved in
previous studies.
Data collection and analysis
Selection of studies
The search strategy described will be used to obtain titles and
abstracts of studies that may be relevant to the review. The titles
and abstracts will be screened independently by two authors, who
will discard studies that are not applicable; however studies and
reviews that might include relevant data or information on studies
will be retained initially. Two authors will independently assess
retrieved abstracts and, if necessary the full text, of these studies
to determine which studies satisfy the inclusion criteria.
Data extraction and management
Data extraction will be carried out independently by two authors
using standard data extraction forms. Studies reported in non-
English language journals will be translated before assessment.
Where more than one publication of one study exists, reports will
be grouped together and the publication with the most complete
data will be used in the analyses. Where relevant outcomes are
only published in earlier versions these data will be used. Any
discrepancy between published versions will be highlighted.
Assessment of risk of bias in included studies
The following items will be independently assessed by two authors
using the risk of bias assessment tool (Higgins 2011) (see Appendix
2).
• Was there adequate sequence generation (selection bias)?
• Was allocation adequately concealed (selection bias)?
• Was knowledge of the allocated interventions adequately
prevented during the study?
◦ Participants and personnel (performance bias)
◦ Outcome assessors (detection bias)
• Were incomplete outcome data adequately addressed
(attrition bias)?
• Are reports of the study free of suggestion of selective
outcome reporting (reporting bias)?
• Was the study apparently free of other problems that could
put it at a risk of bias?
Measures of treatment effect
For dichotomous outcomes (peritonitis rate at two weeks, exit site
infection rate, postoperative haemorrhage rate, cathetermigration)
results will be expressed as risk ratio (RR) with 95% confidence
intervals (CI).
Where continuous scales of measurement are used to assess the
effects of treatment (catheter survival) methods of survival anal-
ysis will be used including hazard ratios, If change from baseline
scores are reported in studies, these will be included if appropri-
ate. Missing standard deviations will be dealt with via imputation
techniques.
Skewed data and non-quantitative data will be presented descrip-
tively.
Unit of analysis issues
Studies with non-standard designs such as multiple intervention
groups and cluster RCTs will be included depending on study
design. For cluster RCTs, the unit of analysis will be the individual
patient however if the unit of randomisation in the study does
not match the unit of analysis, these will be subject to statistical
modelling as outlined in the Cochrane Handbook of Systematic
Reviews (Higgins 2011).
Dealing with missing data
Any further information required from the original author will be
requested by written correspondence (e.g. emailing corresponding
author/s) and any relevant information obtained in this manner
will be included in the review. Evaluation of important numerical
data such as screened, randomised patients as well as intention-to-
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treat, as-treated and per-protocol population will be carefully per-
formed. Attrition rates, for example drop-outs, losses to follow-up
and withdrawals will be investigated and sensitivity analysis used
to assess the impact of inclusion of these studies. Issues of missing
data and imputation methods (for example, last-observation-car-
ried-forward) will be critically appraised (Higgins 2011) and the
most appropriate method selected.
Assessment of heterogeneity
We will first assess the heterogeneity by visual inspection of the
forest plot. We will quantify statistical heterogeneity using the I
2 statistic, which describes the percentage of total variation across
studies that is due to heterogeneity rather than sampling error
(Higgins 2003). A guide to the interpretation of I2 values will be
as follows.
• 0% to 40%: might not be important
• 30% to 60%: may represent moderate heterogeneity
• 50% to 90%: may represent substantial heterogeneity
• 75% to 100%: considerable heterogeneity.
The importance of the observed value of I2 depends on the mag-
nitude and direction of treatment effects and the strength of evi-
dence for heterogeneity (e.g. P-value from the Chi2 test, or a con-
fidence interval for I2) (Higgins 2011).
Assessment of reporting biases
If possible, funnel plots will be used to assess for the potential
existence of small study bias (Higgins 2011).
Data synthesis
Data will be pooled using the random-effects model but the fixed-
effect model will also be used to ensure robustness of the model
chosen and susceptibility to outliers.
Subgroup analysis and investigation of heterogeneity
Subgroup analysis will be used to explore possible sources of
heterogeneity (e.g. participants, interventions and study quality).
Heterogeneity among participants could be related to age, sex,
kidney pathology, diabetic status, body mass index (BMI) or prior
surgical intervention. Heterogeneity in intervention (procedure)
could relate to operator type or number of operators. Adverse ef-
fects will be tabulated and assessed with descriptive techniques, as
they are likely to be different for the various insertion techniques
used. Where possible, the risk difference with 95% CI will be cal-
culated for each adverse effect, either compared to no treatment
or to another procedure type.
Sensitivity analysis
We will perform sensitivity analyses in order to explore the influ-
ence of the following factors on effect size.
• Repeating the analysis excluding unpublished studies
• Repeating the analysis taking account of risk of bias, as
specified
• Repeating the analysis excluding any very long or large
studies to establish how much they dominate the results
• Repeating the analysis excluding studies using the following
filters: diagnostic criteria, language of publication, source of
funding (industry versus other), and country.
’Summary of findings’ tables
We will present the main results of the review in ’Summary of
findings’ tables. These tables present key information concerning
the quality of the evidence, the magnitude of the effects of the
interventions examined, and the sum of the available data for the
main outcomes (Schünemann 2011a). The ’Summary of findings’
tables also include an overall grading of the evidence related to
each of the main outcomes using the GRADE (Grades of Recom-
mendation, Assessment, Development and Evaluation) approach
(GRADE 2008). The GRADE approach defines the quality of a
body of evidence as the extent to which one can be confident that
an estimate of effect or association is close to the true quantity of
specific interest. The quality of a body of evidence involves consid-
eration of within-trial risk of bias (methodological quality), direct-
ness of evidence, heterogeneity, precision of effect estimates and
risk of publication bias (Schünemann 2011b). We plan to present
the following outcomes in the ’Summary of findings’ tables.
1. Catheter survival: divided according to time window
available from the data
2. Technique failure: divided according to time window from
the available data
3. Surgical complications: hernias, leaks, haemorrhage
4. Infection: peritonitis, exit site infection, tunnel infection
5. Patient reported outcome measures: if reported (e.g.
catheter related pain)
6. Catheter flow: if documented
7. Catheter tip migration: if documented.
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A P P E N D I C E S
Appendix 1. Electronic search strategies
Database Search terms
CENTRAL 1. MeSH descriptor: [Renal Replacement Therapy] this term only
2. MeSH descriptor: [Peritoneal Dialysis] explode all trees
3. peritoneal dialysis:ti,ab,kw (Word variations have been searched)
4. PD or CAPD or CCPD or APD:ti,ab,kw (Word variations have been searched)
5. {or #1-#4}
6. MeSH descriptor: [Catheters, Indwelling] this term only
7. MeSH descriptor: [Catheters] this term only
8. MeSH descriptor: [Catheterization] this term only
9. catheter insert* or catheter implant*:ti,ab,kw (Word variations have been searched)
10. (peritoneal dialysis or PD) and catheter*:ti,ab,kw (Word variations have been searched)
11. “blind percutaneous” or peritoneoscopic or fluoroscopic or laparoscopic:ti,ab,kw (Word variations have been
searched)
12. MeSH descriptor: [Fluoroscopy] this term only
13. MeSH descriptor: [Laparoscopy] explode all trees
14. {or #6-#13}
15. {and #5, #14}
MEDLINE 1. Renal Replacement Therapy/
2. exp Peritoneal Dialysis/
3. peritoneal dialysis.tw.
4. (PD or CAPD or CCPD or APD).tw.
5. or/1-4
6. Catheters, Indwelling/
7. Catheters/
8. Catheterization/
9. (catheter insertion or catheter implant$).tw.
10. ((peritoneal dialysis or PD) and catheter$).tw.
11. (blind percutaneous or peritoneoscopic or fluoroscopic or laparoscopic).tw.
12. Fluoroscopy/
13. Laparoscopy/
14. or/6-13
15. and/5,14
EMBASE 1. Peritoneal Dialysis/
2. Continuous Ambulatory Peritoneal Dialysis/
3. peritoneal dialysis.tw.
4. (PD or CAPD or CCPD or APD).tw.
5. renal replacement therapy-dependent renal disease/
6. or/1-5
7. peritoneal dialysis catheter/
8. catheterization/
9. peritoneal dialysis catheter$.tw.
10. (catheter insertion or catheter implant$).tw.
9Catheter insertion techniques for improving catheter function and clinical outcomes in peritoneal dialysis patients (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
11. ((peritoneal dialysis or PD) and catheter$).tw.
12. (blind percutaneous or peritoneoscopic or fluoroscopic or laparoscopic).tw.
13. fluoroscopy/
14. laparoscopy/
15. or/7-14
16. and/6,15
Appendix 2. Risk of bias assessment tool
Potential source of bias Assessment criteria
Random sequence generation
Selection bias (biased allocation to interventions) due to inade-
quate generation of a randomised sequence
Low risk of bias: Random number table; computer random num-
ber generator; coin tossing; shuffling cards or envelopes; throwing
dice; drawing of lots; minimisation (minimisation may be imple-
mented without a random element, and this is considered to be
equivalent to being random)
High risk of bias: Sequence generated by odd or even date of birth;
date (or day) of admission; sequence generated by hospital or
clinic record number; allocation by judgement of the clinician; by
preference of the participant; based on the results of a laboratory
test or a series of tests; by availability of the intervention
Unclear: Insufficient information about the sequence generation
process to permit judgement
Allocation concealment
Selection bias (biased allocation to interventions) due to inade-
quate concealment of allocations prior to assignment
Low risk of bias: Randomisation method described that would not
allow investigator/participant to know or influence intervention
group before eligible participant entered in the study (e.g. central
allocation, including telephone, web-based, and pharmacy-con-
trolled, randomisation; sequentially numbered drug containers of
identical appearance; sequentially numbered, opaque, sealed en-
velopes)
High risk of bias:Using an open random allocation schedule (e.g. a
list of random numbers); assignment envelopes were used without
appropriate safeguards (e.g. if envelopes were unsealed or non-
opaque or not sequentially numbered); alternation or rotation;
date of birth; case record number; any other explicitly unconcealed
procedure
Unclear: Randomisation stated but no information on method
used is available
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(Continued)
Blinding of participants and personnel
Performance bias due to knowledge of the allocated interventions
by participants and personnel during the study
Low risk of bias: No blinding or incomplete blinding, but the re-
view authors judge that the outcome is not likely to be influenced
by lack of blinding; blinding of participants and key study per-
sonnel ensured, and unlikely that the blinding could have been
broken
High risk of bias: No blinding or incomplete blinding, and the
outcome is likely to be influenced by lack of blinding; blinding
of key study participants and personnel attempted, but likely that
the blinding could have been broken, and the outcome is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
Blinding of outcome assessment
Detection bias due to knowledge of the allocated interventions by
outcome assessors
Low risk of bias:Noblinding of outcome assessment, but the review
authors judge that the outcome measurement is not likely to be
influenced by lack of blinding; blinding of outcome assessment
ensured, and unlikely that the blinding could have been broken
High risk of bias: No blinding of outcome assessment, and the
outcome measurement is likely to be influenced by lack of blind-
ing; blinding of outcome assessment, but likely that the blinding
could have been broken, and the outcome measurement is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
Incomplete outcome data
Attrition bias due to amount, nature or handling of incomplete
outcome data
Low risk of bias: No missing outcome data; reasons for missing
outcome data unlikely to be related to true outcome (for survival
data, censoring unlikely to be introducing bias); missing outcome
data balanced in numbers across intervention groups, with similar
reasons for missing data across groups; for dichotomous outcome
data, the proportion ofmissing outcomes comparedwith observed
event risk not enough to have a clinically relevant impact on the
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardised difference in
means) among missing outcomes not enough to have a clinically
relevant impact on observed effect size; missing data have been
imputed using appropriate methods
High risk of bias: Reason for missing outcome data likely to be
related to true outcome, with either imbalance in numbers or rea-
sons for missing data across intervention groups; for dichotomous
outcome data, the proportion ofmissing outcomes comparedwith
observed event risk enough to induce clinically relevant bias in
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardized difference in
means) among missing outcomes enough to induce clinically rel-
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(Continued)
evant bias in observed effect size; ‘as-treated’ analysis done with
substantial departure of the intervention received from that as-
signed at randomisation; potentially inappropriate application of
simple imputation
Unclear: Insufficient information to permit judgement
Selective reporting
Reporting bias due to selective outcome reporting
Low risk of bias: The study protocol is available and all of the
study’s pre-specified (primary and secondary) outcomes that are of
interest in the review have been reported in the pre-specified way;
the study protocol is not available but it is clear that the published
reports include all expected outcomes, including those that were
pre-specified (convincing text of this nature may be uncommon)
High risk of bias: Not all of the study’s pre-specified primary out-
comes have been reported; one or more primary outcomes is re-
ported using measurements, analysis methods or subsets of the
data (e.g. sub-scales) that were not pre-specified; one or more re-
ported primary outcomes were not pre-specified (unless clear jus-
tification for their reporting is provided, such as an unexpected
adverse effect); one or more outcomes of interest in the review are
reported incompletely so that they cannot be entered in a meta-
analysis; the study report fails to include results for a key outcome
that would be expected to have been reported for such a study
Unclear: Insufficient information to permit judgement
Other bias
Bias due to problems not covered elsewhere in the table
Low risk of bias: The study appears to be free of other sources of
bias.
High risk of bias: Had a potential source of bias related to the spe-
cific study design used; stopped early due to some data-dependent
process (including a formal-stopping rule); had extreme baseline
imbalance; has been claimed to have been fraudulent; had some
other problem
Unclear: Insufficient information to assess whether an important
risk of bias exists; insufficient rationale or evidence that an iden-
tified problem will introduce bias
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